SELL Bandhan Bank Limited — Manas Jaiswal
Bandhan Bank share price target & all analyst calls
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))8 Jul 2026via CNBC Awaaz.
Entry₹198Inferred
Stop loss₹202-2.02% risk
Exit₹20210 Jul 2026, 9:20 am
Stop-loss hit-2.02%
Follow Manas Jaiswal for new calls(30% target hit, 380 closed calls)Get alertsWatch BANDHANBNK for new buy/sell callsGet alertsSee 149 active Swing picks this week
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
1 supporting1 opposing
Supports the SELL call (1)
Neutral / worth noting (0)
Nothing found in this tip’s window yet.
Weighs against the SELL call (1)
2 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·1 Jun · 1mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Bandhan Bank
- BUY — Manas Jaiswal23 Sept 2026 · ~2 weeks · target ₹200 · SL hit
- BUY — Nirav Chheda, Nirmal Bang Securities22 Sept 2026 · ~2 weeks · target ₹195 · SL hit
- BUY — Vishnu Kant Upadhyay, Master Capital Services22 Sept 2026 · ~3 months · target ₹198 · SL hit
- BUY — Sumeet Bagadia, Choice Broking22 Sept 2026 · Same day · target ₹188 · Expired
- BUY — Manas Jaiswal21 Sept 2026 · ~2 weeks · target ₹187 · Target hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

